Phase II Study of Regorafenib as Maintenance Therapy

Clinical trial NCT03793361 · COMPLETED

Trial details

NCT number: NCT03793361
Sponsor: Centre Oscar Lambret
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Soft Tissue Sarcoma

Start date: 2019-05-15
Primary completion: 2024-03-15
Enrollment: 127

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.